#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Diabetes and obesity - Issue 40/2020

Editorial

73

Personal news

74

Spomienka na Borisa Krahulca

Reviews

78

Clinical data on the use of insulin glargine 300 U/ml in adult and paediatric populations with type 1 diabetes and their meta-analysis

Peter Novodvorský

84

Metformin treatment is still under discussion

Zbynek Schroner, Vladimír Uličiansky

88

GDF15: a new predictive biomarker for type 2 diabetes mellitus in clinical practice

Andrej Dukát, Juraj Payer, Fedor Šimko

93

Impaired awareness of hypoglycaemia: management and experience from Sheffield

Peter Novodvorský, Andrei Oprescu, Jackie Elliott, Simon R Heller

99

Presence of alcohol in the breath of a diabetic patient – a possible forensic problem

Jana Gáliková

103

Does diabetes support cancer development?

Ján Murín

Case studies

108

Remission of nocturnal hypoglycemia after a change in basal insulin

Daniela Kollárová

110

Biosimilar insulin glargine added to treatment with oral antidiabetics

Marek Macko

112

A basal analogue highly effective even in patients after kidney transplantation

Miroslav Paľko

Clinical studies

114

Study EMPEROR-Reduced: design, results and implications for clinical practice

Zbynek Schroner

News

117

Do we need „cardio-metabolic“ specialists?

Ján Murín

News

119

80. virtuálna konferencia American Diabetes Association

Martin Haluzík, Zbynek Schroner

124

Rozšírenie technológií do diabetologickej praxe

Viera Doničová

125

Jubilejné XXX. diabetologické dni s medzinárodnou účasťou

Vladimír Uličiansky

Diabetes and obesity

Issue 40

2020 Issue 40

Most read in this issue

#ADS_BOTTOM_SCRIPTS#